MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 289 filers reported holding MYRIAD GENETICS INC in Q2 2014. The put-call ratio across all filers is 3.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $251,767 | -23.0% | 15,696 | +11.3% | 0.00% | – |
| Q2 2023 | $326,934 | -3.3% | 14,104 | -3.1% | 0.00% | – |
| Q1 2023 | $337,947 | +85.5% | 14,548 | +15.9% | 0.00% | – |
| Q4 2022 | $182,192 | -45.6% | 12,556 | -28.5% | 0.00% | -100.0% |
| Q3 2022 | $335,000 | +10.6% | 17,554 | +5.4% | 0.00% | – |
| Q2 2022 | $303,000 | -32.7% | 16,657 | -6.7% | 0.00% | -100.0% |
| Q1 2022 | $450,000 | -13.3% | 17,845 | -5.2% | 0.00% | 0.0% |
| Q4 2021 | $519,000 | -18.5% | 18,821 | -4.5% | 0.00% | 0.0% |
| Q3 2021 | $637,000 | +5.1% | 19,712 | -0.5% | 0.00% | 0.0% |
| Q2 2021 | $606,000 | -12.3% | 19,805 | -12.9% | 0.00% | 0.0% |
| Q1 2021 | $691,000 | +120.8% | 22,726 | +43.7% | 0.00% | 0.0% |
| Q4 2020 | $313,000 | +64.7% | 15,815 | +8.0% | 0.00% | – |
| Q3 2020 | $190,000 | -37.3% | 14,643 | -45.3% | 0.00% | -100.0% |
| Q2 2020 | $303,000 | -8.7% | 26,747 | +14.7% | 0.00% | 0.0% |
| Q1 2020 | $332,000 | -84.9% | 23,323 | -71.1% | 0.00% | -80.0% |
| Q4 2019 | $2,199,000 | +200.0% | 80,680 | +214.8% | 0.01% | +150.0% |
| Q3 2019 | $733,000 | -65.5% | 25,626 | -66.5% | 0.00% | -60.0% |
| Q2 2019 | $2,122,000 | +321.0% | 76,427 | +404.4% | 0.01% | +400.0% |
| Q1 2019 | $504,000 | -76.5% | 15,151 | -79.4% | 0.00% | -85.7% |
| Q4 2018 | $2,142,000 | -22.9% | 73,670 | +22.0% | 0.01% | -12.5% |
| Q3 2018 | $2,777,000 | +30.3% | 60,385 | +5.8% | 0.01% | +14.3% |
| Q2 2018 | $2,132,000 | +33.2% | 57,068 | +5.4% | 0.01% | +40.0% |
| Q1 2018 | $1,600,000 | -12.9% | 54,143 | +1.2% | 0.01% | -16.7% |
| Q4 2017 | $1,838,000 | -6.6% | 53,508 | -1.7% | 0.01% | -14.3% |
| Q3 2017 | $1,968,000 | +45.1% | 54,408 | +3.6% | 0.01% | +40.0% |
| Q2 2017 | $1,356,000 | +192.9% | 52,508 | +389.9% | 0.01% | +150.0% |
| Q4 2015 | $463,000 | +70.2% | 10,718 | +52.0% | 0.00% | 0.0% |
| Q3 2014 | $272,000 | -21.8% | 7,053 | -30.7% | 0.00% | -33.3% |
| Q1 2014 | $348,000 | – | 10,184 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |